Indication

Enterobacter meningitis

Enterobacter meningitis is a severe, life-threatening bacterial infection characterized by acute inflammation of the protective leptomeninges surrounding the brain and spinal cord, caused by Gram-negative bacilli of the genus *Enterobacter* (predominantly members of the *Enterobacter cloacae* complex). Read more about Enterobacter meningitis

16 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Enterobacter meningitis therapies.

Showing 10–16 of 16 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Hikma Pharmaceuticals USA

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Avet Pharmaceuticals

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
AVET-NOVAPLUS

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
MULLAN PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Enterobacter meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Enterobacter meningitis.

Enterobacter meningitis is a severe, life-threatening bacterial infection characterized by acute inflammation of the protective leptomeninges surrounding the brain and spinal cord, caused by Gram-negative bacilli of the genus *Enterobacter* (predominantly members of the *Enterobacter cloacae* complex).

Although uncommon overall, it predominantly occurs as a healthcare-associated or nosocomial central nervous system infection in neurosurgical patients, individuals with head trauma, patients with indwelling cerebrospinal fluid devices, and immunocompromised hosts or neonates.

Clinical features typically include fever, altered mental status, meningismus, seizures, and marked cerebrospinal fluid pleocytosis with elevated protein and decreased glucose.

Management is notably challenging due to the frequent presence of inducible chromosomal AmpC beta-lactamases and acquired multidrug resistance mechanisms that limit standard antimicrobial therapy.

Personalize your experience

Follow Enterobacter meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it